Sunitinib G.L. Pharma
← BackMedicinal product
Sunitinib G.L. Pharma
Sunitinibas
12,5 mg
kietosios kapsulės
vartoti per burną
Receptinis
No
L01EX01, sunitinib
G.L. Pharma GmbH, Austrija
2020-12-22
2025-08-21
Perregistruotas
No
10(1)
NL/H/4975/001/DC
Decentralizuota procedūra
Qualitative and quantitative composition
Kapsulėje yra | 1 vnt. |
---|---|
Sunitinibas | 12,5 mg |
Packages
PAKID | NPAKID | NPAKID-7 | Pack type | Pack size | Type of packaging | Proposed dispensing/classification | Marketing authorisation no. | Supply status | From | To | Package is in foreign language | From | To | Mock-up |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
105557 | 91657 | 1091657 | lizdinė plokštelė | N28 | Receptinis | LT/1/20/4662/001 | Netiekiama | - | - | No | - | - | ||
105558 | 91658 | 1091658 | lizdinė plokštelė | N30 | Receptinis | LT/1/20/4662/002 | Tiekiama | - | - | No | - | - | Download |
Stadijos
Data | Stadija |
---|---|
2025-08-21 | Perregistruotas |
2020-12-22 | Registruotas |